• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

ecg

​​AliveCor Unveils KardiaMobile 6L Max & KardiaAlert for Advanced Personal ECG Monitoring

by Fred Pennic 05/06/2025 Leave a Comment

​​AliveCor Unveils KardiaMobile 6L Max & KardiaAlert for Advanced Personal ECG Monitoring

What You Should Know:  - AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal ECG system, the AI-powered KardiaMobile® 6L Max.  - Accompanying this device is KardiaAlert™, a first-of-its-kind feature available exclusively to subscribers of AliveCor's KardiaCare service. Together, these innovations aim to provide users with more comprehensive detections and insights, monitor heart rhythms for
Read More

HeartBeam & AccurKardia Integrates Advanced ECG Analysis into Cardiac Monitoring Platform

by Fred Pennic 04/24/2025 Leave a Comment

HeartBeam & AccurKardia Integrates Advanced ECG Analysis into Cardiac Monitoring Platform

What You Should Know:  - HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a strategic collaboration with AccurKardia, an innovator in ECG-based diagnostics technology.  - The partnership unites two innovation leaders in ambulatory electrocardiogram (ECG) recording and analysis, aiming to enhance the accessibility of advanced cardiac monitoring solutions. Integrating Advanced ECG Analysis
Read More

Smartaly and Ambiq to Develop AI-Powered, Week-Long ECG Monitor

by Jasmine Pennic 03/19/2024 Leave a Comment

Smartaly and Ambiq to Develop AI-Powered, Week-Long ECG Monitor

What You Should Know: - Ambiq, a leader in low-power semiconductors, and Smartaly, an electronics design firm, have partnered to create an artificial intelligence (AI) powered handheld ECG monitor. - The AI-powered ECG monitor device boasts not only exceptional battery life but also the power of AI for real-time health insights. Week-long Monitoring on a Single Charge Smartaly's ECG monitor leverages Ambiq's Apollo3 SoC, a third-generation system on a chip (SoC) specifically designed
Read More

AccurKardia Brings ECG Software to Lucem Health’s AI Platform

by Jasmine Pennic 11/10/2023 Leave a Comment

AccurKardia Brings ECG Software to Lucem Health's AI Platform

What You Should Know: - AccurKardia, an ECG-led diagnostics software company, has announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. - The partnership will allow AccurKardia to integrate its FDA-cleared ECG interpretation software platform, AccurECG, into Lucem Health's Reveal family of solutions, which identify patients who may be at higher risk of severe or chronic diseases. Automated ECG Interpretation Cloud-Based Software
Read More

iRhythm Launches Wearable ECG Heart Monitor

by Syed Hamza Sohail 09/26/2023 Leave a Comment

iRhythm Launches Wearable ECG Heart Monitor

What You Should Know: iRhythm Technologies, Inc. today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous monitoring (LTCM) service.Zio monitor is iRhythm’s smallest, lightest and thinnest cardiac monitor, enhancing the cardiac monitoring experience for patients and healthcare providers together with new service enhancements. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service.
Read More

FDA Clears Samsung’s Irregular Heart Rhythm Notification

by Fred Pennic 05/08/2023 Leave a Comment

FDA Clears Samsung’s Irregular Heart Rhythm Notification

What You Should Know: Today, Samsung announced today its Irregular Heart Rhythm Notification feature of the Samsung Health Monitor App has been cleared by the FDA. With this new feature, Galaxy Watch users can be alerted when heart rhythms suggestive of atrial fibrillation (AFib) – a type of arrhythmia – are detected.The Irregular Heart Rhythm Notification works with the app’s existing on-demand Electrocardiogram function to proactively monitor heart rhythms suggestive of AFib, and
Read More

Risky Business of Health Trackers: What Digital Health Leaders Need to Know

by Cristina Varner, Newfront, SVP National Life Science & Healthcare Practice 03/09/2023 Leave a Comment

Risky Business of Health Trackers; What Digital Health Leaders Need to Know

Gone are the days when healthcare information was only available to us at the doctor’s office or through the office's online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices. It’s estimated that 1 in 5 adults in the U.S. use a fitness or health tracker to monitor things such as heart rate, blood pressure, sleep cycle, and stress. But this information is being used beyond just monitoring specific conditions. Take me, for example; I personally use my
Read More

KLAS Names Chartis, Nordic, Tegria Top Performers for IT Advisory Services

by Syed Hamza Sohail 02/22/2023 Leave a Comment

KLAS Names Chartis, Nordic, Tegria Top Performers for IT Advisory Services

What You Should Know: - In the IT advisory space, many firms perform well, but the breadth of their expertise varies—some firms offer many services, while others focus on a specific area. KLAS's latest report examines the breadth of firms’ validated services as well as client satisfaction and performance consistency. - To provide better transparency into IT advisory services, KLAS has broken them into the following four segments: IT planning and assessment, revenue cycle optimization,
Read More

The Quickening Pulse of the Ambulatory Diagnostic Cardiology Market

by Kelly Patrick, Principal Analyst at Signify Research 02/14/2023 Leave a Comment

Quickening Pulse of the Ambulatory Diagnostic Cardiology Market

The Global Ambulatory Diagnostic Cardiology Market is evolving at a rapid pace, driven by technological developments, and shifting models of healthcare service delivery and funding. The overall market will grow from $2.5 billion in 2021, to $3.3 billion by 2026, with Long-Term ECG and, to a lesser extent, Mobile Cardiac Telemetry (MCT), being the principal engines of growth. Unsurprisingly, these two markets are garnering serious attention from large incumbent vendors in the more established
Read More

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

by Fred Pennic 12/15/2022 Leave a Comment

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

What You Should Know: - Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis. - Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 7
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |